Macquarie Initiates Coverage on ILUVATAR COREX with Outperform Rating and HK$1240 Target

Stock News

Jul 01

Macquarie has released a research report, initiating coverage on Hong Kong-listed ILUVATAR COREX (09903) with an "Outperform" investment rating and a target price of HK$1240.

The report identifies the company as a leading domestic enterprise in the field of general-purpose GPUs (GPGPU), possessing the longest development history in this sector within China.

Supported by a diverse product portfolio and a mature supply chain, the company has established itself as a strong competitor for market share in the domestic AI chip arena.

The analysis further highlights that the company's relatively extensive industry experience in GPGPU chip design and its established supply chain system form its core differentiating advantages, granting it higher operational efficiency and greater earnings predictability compared to peers.

Regarding financial projections, Macquarie anticipates the company will maintain robust revenue growth momentum, forecasting a compound annual growth rate of 120% from 2025 to 2028, with revenue expected to exceed 11 billion yuan by 2028.

On the profitability front, driven by increasing revenue scale and product mix upgrades, the company is projected to achieve a turnaround to profitability by 2027, marking the beginning of its earnings realization phase.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1115798696"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1115798696\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1115798696?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-01 18:36","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1115798696","market":"other","top_or_hot":-1,"title":"Macquarie Initiates Coverage on ILUVATAR COREX with Outperform Rating and HK$1240 Target","media":"Stock News","content":"<p>Macquarie has released a research report, initiating coverage on Hong Kong-listed <b>ILUVATAR COREX</b> (<b>09903</b>) with an \"Outperform\" investment rating and a target price of HK$1240.<br><br>The report identifies the company as a leading domestic enterprise in the field of general-purpose GPUs (GPGPU), possessing the longest development history in this sector within China.<br><br>Supported by a diverse product portfolio and a mature supply chain, the company has established itself as a strong competitor for market share in the domestic AI chip arena.<br><br>The analysis further highlights that the company's relatively extensive industry experience in GPGPU chip design and its established supply chain system form its core differentiating advantages, granting it higher operational efficiency and greater earnings predictability compared to peers.<br><br>Regarding financial projections, Macquarie anticipates the company will maintain robust revenue growth momentum, forecasting a compound annual growth rate of 120% from 2025 to 2028, with revenue expected to exceed 11 billion yuan by 2028.<br><br>On the profitability front, driven by increasing revenue scale and product mix upgrades, the company is projected to achieve a turnaround to profitability by 2027, marking the beginning of its earnings realization phase.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Macquarie Initiates Coverage on ILUVATAR COREX with Outperform Rating and HK$1240 Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMacquarie Initiates Coverage on ILUVATAR COREX with Outperform Rating and HK$1240 Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-07-01 18:36</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Macquarie has released a research report, initiating coverage on Hong Kong-listed <b>ILUVATAR COREX</b> (<b>09903</b>) with an \"Outperform\" investment rating and a target price of HK$1240.<br><br>The report identifies the company as a leading domestic enterprise in the field of general-purpose GPUs (GPGPU), possessing the longest development history in this sector within China.<br><br>Supported by a diverse product portfolio and a mature supply chain, the company has established itself as a strong competitor for market share in the domestic AI chip arena.<br><br>The analysis further highlights that the company's relatively extensive industry experience in GPGPU chip design and its established supply chain system form its core differentiating advantages, granting it higher operational efficiency and greater earnings predictability compared to peers.<br><br>Regarding financial projections, Macquarie anticipates the company will maintain robust revenue growth momentum, forecasting a compound annual growth rate of 120% from 2025 to 2028, with revenue expected to exceed 11 billion yuan by 2028.<br><br>On the profitability front, driven by increasing revenue scale and product mix upgrades, the company is projected to achieve a turnaround to profitability by 2027, marking the beginning of its earnings realization phase.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1163","symbol_name":"半导体产品","start_time":0,"source_url":"","article_id":"1115798696","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1115798696","pubTimestamp":1782902195,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Macquarie has released a research report, initiating coverage on Hong Kong-listed ILUVATAR COREX (09903) with an \"Outperform\" investment rating and a target price of HK$1240.The report identifies the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1163":"半导体产品","EWH":"香港ETF-iShares MSCI","09903":"天数智芯"},"translate_title":"麦格理首次覆盖ILUVATAR COREX，给予跑赢大盘评级，目标价1240港元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EWH":1,"09903":1},"content_text":"Macquarie has released a research report, initiating coverage on Hong Kong-listed ILUVATAR COREX (09903) with an \"Outperform\" investment rating and a target price of HK$1240.The report identifies the company as a leading domestic enterprise in the field of general-purpose GPUs (GPGPU), possessing the longest development history in this sector within China.Supported by a diverse product portfolio and a mature supply chain, the company has established itself as a strong competitor for market share in the domestic AI chip arena.The analysis further highlights that the company's relatively extensive industry experience in GPGPU chip design and its established supply chain system form its core differentiating advantages, granting it higher operational efficiency and greater earnings predictability compared to peers.Regarding financial projections, Macquarie anticipates the company will maintain robust revenue growth momentum, forecasting a compound annual growth rate of 120% from 2025 to 2028, with revenue expected to exceed 11 billion yuan by 2028.On the profitability front, driven by increasing revenue scale and product mix upgrades, the company is projected to achieve a turnaround to profitability by 2027, marking the beginning of its earnings realization phase.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}